Status:
UNKNOWN
The Effect and Mechanism of Gene Variation on Neonatal Hyperbilirubinemia
Lead Sponsor:
Sixth Affiliated Hospital, Sun Yat-sen University
Conditions:
Neonatal Hyperbilirubinemia
Eligibility:
All Genders
1-28 years
Brief Summary
Neonatal hyperbilirubinemia ( NHB ) has many causes and is difficult to diagnose, and genetic factors play an important role in the metabolism of bilirubin. However, there is no literature report on t...
Detailed Description
Adverse reactions: In this study, only 3 drops of neonatal heel peripheral blood were collected for genetic analysis and statistical analysis of percutaneous jaundice values. No human trials were invo...
Eligibility Criteria
Inclusion
- Age 1-28 days
- gestational age ≥ 35 weeks
- Birth weight ≥ 2.5 kg and \< 4 kg.
Exclusion
- Neonatal data with unclear clinical basic information ;
- Lack of traceability core information data ;
- data that the test results cannot be analyzed and interpreted ;
- Sample collection is not qualified and unwilling to cooperate with re-sampling.
- Newborns with severe deformity and severe lethal inherited metabolic diseases
Key Trial Info
Start Date :
September 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT06186349
Start Date
September 1 2023
End Date
December 31 2024
Last Update
January 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Sixth Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, China, 510655